Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BB BIOTECH : Independant Research reaffirms its Neutral rating

08/27/2019 | 07:02am EST

Analyst Tobias Gottschalt from Independant Research research gives the stock a Neutral rating. The target price is slightly modified from 64 to 63 EUR.


ę MarketScreener with dpa-AFX Analyser 2019
All news about BB BIOTECH AG
01/21BB Biotech Forecasts Switch to FY21 Loss in 'Difficult Year'
MT
01/21BB Biotech AG closes the 2021 fiscal year with a loss
EQ
01/21BB BIOTECH AG : 2021 was a difficult year for biotech equity markets - increased dividend ..
EQ
01/21BB Biotech AG Proposes a Regular Dividend
CI
2021BB BIOTECH : źCancer medicine improves the chances of a cure╗
PU
2021BB Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
2021BB BIOTECH : Q3 Net Loss Shrinks
MT
2021BB BIOTECH : increases positions in oncology and CNS
PU
2021BB BIOTECH : publishes its interim report
EQ
2021BB BIOTECH : Gains realized following COVID-19 vaccine booster update enable increases in ..
EQ
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Financials
Sales 2021 159 M 173 M 173 M
Net income 2021 374 M 406 M 406 M
Net Debt 2021 53,9 M 58,6 M 58,6 M
P/E ratio 2021 8,13x
Yield 2021 6,32%
Capitalization 3 623 M 3 942 M 3 941 M
EV / Sales 2021 23,2x
EV / Sales 2022 12,0x
Nbr of Employees 10
Free-Float -
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 63,25 CHF
Average target price 97,00 CHF
Spread / Average Target 53,4%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG-18.02%3 829
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842